Authors: DELONG RK NOLTING A FISHER M CHEN Q WICKSTROM E KLIGSHTEYN M DEMIRDJI S CARUTHERS M JULIANO RL

Citation: Rk. Delong et al., COMPARATIVE PHARMACOKINETICS, TISSUE DISTRIBUTION, AND TUMOR ACCUMULATION OF PHOSPHOROTHIOATE, PHOSPHORODITHIOATE, AND METHYLPHOSPHONATE OLIGONUCLEOTIDES IN NUDE-MICE, ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 7(2), 1997, pp. 71-77

Authors: HUANG Y SNYDER R KLIGSHTEYN M WICKSTROM E

Citation: Y. Huang et al., PREVENTION OF TUMOR-FORMATION IN A MOUSE MODEL OF BURKITTS-LYMPHOMA BY 6 WEEKS OF TREATMENT WITH ANTI-C-MYC DNA PHOSPHOROTHIOATE, Molecular medicine, 1(6), 1995, pp. 647-658

Authors: HUANG Y SNYDER R KLIGSHTEYN M WICKSTROM E

Citation: Y. Huang et al., PREVENTION OF B-CELL LYMPHOMA IN EU-MYC TRANSGENIC MICE BY 6 WEEKS OFTREATMENT WITH ANTI-C-MYC DNA PHOSPHOROTHIOATE, The FASEB journal, 9(3), 1995, pp. 409-409

Authors: WICKSTROM E HUANG Y GRAY GD KLIGSHTEYN M

Citation: E. Wickstrom et al., LONG-TERM ANTISENSE DNA ADMINISTRATION IN C-MYC TRANSGENIC MICE AND IN NUDE-MICE BEARING C-HA-RAS INDUCED-TUMORS, The FASEB journal, 8(7), 1994, pp. 10001448-10001448